Literature DB >> 11909744

Proteins in the chlamydial inclusion membrane.

Daniel D Rockey1, Marci A Scidmore, John P Bannantine, Wendy J Brown.   

Abstract

The chlamydiae are obligate intracellular pathogens that occupy a nonacidified vacuole (the inclusion) during their entire developmental cycle. Several proteins have recently been identified that are localized to the inclusion membrane. The following is a discussion of how inclusion membrane proteins might participate in the chlamydial developmental process.

Mesh：

Substances：

Year:  2002        PMID： 11909744     DOI： 10.1016/s1286-4579(02)01546-0

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  89 in total

1.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

2.  Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol.

Authors:  W J Brown; Y A W Skeiky; P Probst; D D Rockey
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

3.  Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.

Authors:  Sandra Muschiol; Gaelle Boncompain; François Vromman; Pierre Dehoux; Staffan Normark; Birgitta Henriques-Normark; Agathe Subtil
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

4.  Genome sequence of the zoonotic pathogen Chlamydophila psittaci.

Authors:  Helena M B Seth-Smith; Simon R Harris; Richard Rance; Anthony P West; Juliette A Severin; Jacobus M Ossewaarde; Lesley T Cutcliffe; Rachel J Skilton; Pete Marsh; Julian Parkhill; Ian N Clarke; Nicholas R Thomson
Journal:  J Bacteriol       Date:  2010-12-23       Impact factor: 3.490

5.  A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Authors:  Sandra Muschiol; Leslie Bailey; Asa Gylfe; Charlotta Sundin; Kjell Hultenby; Sven Bergström; Mikael Elofsson; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

6.  Development of secondary inclusions in cells infected by Chlamydia trachomatis.

Authors:  Robert J Suchland; Daniel D Rockey; Sara K Weeks; Damir T Alzhanov; Walter E Stamm
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

7.  Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Authors:  K Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; K A Fields
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

8.  The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229.

Authors:  K A Rzomp; A R Moorhead; M A Scidmore
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

9.  Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements.

Authors:  P Scott Hefty; Richard S Stephens
Journal:  J Bacteriol       Date:  2006-10-20       Impact factor: 3.490

10.  Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane.

Authors:  Jianhua Luo; Tianjun Jia; Rhonda Flores; Ding Chen; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.